Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Pharmacotherapy. 2010 Mar;30(3):228–235. doi: 10.1592/phco.30.3.228

Table 1.

Patient Demographics at Baseline

Control (n=39)
Number (%) or
Mean (± SD)
Intervention (n=65)
Number (%) or
Mean (± SD)
p-value for
difference
Gender: Female 26 (66.7) 37 (56.9) 0.32
   Male 13 (33.3) 28 (43.1)
Race: Caucasian 38 (97.4) 59 (90.8) 0.19
   Non-Caucasian 1 (2.6) 6 (9.2)
Age (years 62.77 (±11.1) 58.94 (±13.2) 0.13
Married 22 (56.4) 36 (55.4) 0.92
Education beyond high
School
25 (64.1) 39 (60.0) 0.68
Household income < $25,000 8 (20.5) 11 (16.9) 0.65
Insurance status
    Individual or group plan 34 (87.2) 53 (81.5) 0.29
    Medicare/Medicaid 5 (12.8) 8 (12.3)
    Self-pay or other 0 (0.0) 4 (6.2)
BMI (kg/m2) 29.15 (±6.0) 31.99 (±7.2) 0.04
Smoker (within last 15 years) 7 (18.0) 11 (16.9) 0.89
More than 2 alcoholic drinks /
Week
9 (23.1) 21 (32.3) 0.31
Family History of premature
  CV event
10 (25.6) 22 (33.9) 0.38
Diabetes Mellitus 11 (28.2) 17 (26.2) 0.82
Hx Stroke or TIA 4 (10.3) 4 (6.2) 0.47
Hx Myocardial infarction 4 (10.3) 6 (9.2) 0.86
Coronary artery bypass 5 (12.8) 3 (4.6) 0.15
Grafting
Heart failure 1 (2.6) 3 (4.6) 1.0
Angina 1 (2.6) 4 (6.2) 0.65
Peripheral arterial disease 3 (7.7) 5 (7.7) 1.0
Chronic kidney disease 8 (20.5) 15 (23.1) 0.76
Left-ventricular hypertrophy 6 (15.4) 5 (7.7) 0.32
At least one co-existing
Condition*
39 (100) 61 (93.9) 0.11
Number of co-existing
Conditions*
3.31 (±1.7) 2.74 (±2.1) 0.16
At least one antihypertensive 30 (76.9) 57 (87.7) 0.15
Number of antihypertensive 1.33 (±1.0) 1.63 (± 1.0) 0.14
Medications
Baseline medication
Adherence (%)
83.97 (±24.1) 71.59 (±24.0) 0.02

BMI = body mass index, CV = cardiovascular, Hx = history, TIA = transient ischemic attack

*

includes any of the listed co-existing conditions including diabetes mellitus.